Planta Med 2004; 70(7): 637-641
DOI: 10.1055/s-2004-827187
Original Paper
Biochemistry and Molecular Biology
© Georg Thieme Verlag KG Stuttgart · New York

Microbial Metabolism of Pseudoprotodioscin

Mei Dong1 , 4 , Xizhi Feng2 , 4 , Ben-Xiang Wang3 , Takashi Ikejima3 , Li-Jun Wu4
  • 1Department of Cell Biology, Neurobiology, and Anatomy, University of Cincinnati, Cincinnati, Ohio, USA
  • 2Department of Chemistry, University of Virginia, Charlottesville, Virginia, USA
  • 3Research Center of New Drugs, Changchun College of Traditional Chinese Medicine, Changchun, P. R. China
  • 4Department of Natural Medicinal Chemistry, Shenyang Pharmaceutical University, Shenyang, P. R. China
Weitere Informationen

Publikationsverlauf

Received: October 17, 2003

Accepted: April 12, 2004

Publikationsdatum:
15. Juli 2004 (online)

Preview

Abstract

Microbial transformation of the furostanol saponin pseudoprotodioscin (1) using Aspergillus fumigatus resulted in the isolation of two new steroidal metabolites, 3-O-[bis-α-L-rhamnopyranosyl-(1→2 and 1→4)-β-D-glucopyranosyl]-22R,25R-spirost-5-ene-3β,20α-diol (2) and 3-O-[bis-α-L-rhamnopyranosyl-(1→2 and 1→4)-β-D-glucopyranosyl]-25R-furost-5-ene-3β,22α,26-triol (3), in addition to the previously reported steroidal saponins: dioscin (4) and progenin II (5). The structure elucidation of these metabolites was based primarily on 1D and 2D NMR analyses. Metabolites 2 - 5 showed significant cytotoxicity against cancer cell lines A375, L929, and HeLa with IC50 values ranging from 1.18 μM to 17.88 μM.

References

Dr. Xizhi Feng

Department of Chemistry

University of Virginia

P.O. Box 400319

Charlottesville

Virginia 22904-4319

USA

Telefon: +1-434-249-4865

Fax: +1-513-558-2445

eMail: xf3p@virginia.edu